Aims/hypothesis. Study the influence of age, zygosity and birth weight on insulin action and insulin secretion in twins. Methods. In vivo insulin action and insulin secretion were measured using the euglycaemic, hyperinsulinaemic clamp technique and intravenous glucose tolerance test, respectively. We examined 104 monozygotic (MZ) twins and 88 dizygotic (DZ) twins in two age groups (25-34 and 57-66 years).
through "foetal organ programming" [6] . Metabolic studies among humans and in particular among rodents have shown permanent changes in the structure and/or function of involved organs after exposure to an adverse intrauterine environment during critical stages of foetal development leading to the development of two major metabolic abnormalities responsible for the development of overt Type II diabetes i.e. impaired insulin secretion [7, 8, 9, 10, 11, 12] and insulin resistance [13, 14, 15, 16, 17, 18, 19] . However, most human studies have used indirect techniques to measure insulin action including hyperinsulinaemia, HOMA or insulin sensitivity index (MINMOD) [13, 14, 15, 18] , and several studies have failed to show Several epidemiological studies have indicated an influence of the intrauterine environment and in particular of low birth weight for the development of Type II (non-insulin-dependent) diabetes mellitus later in life [1] [2] [3] [4] [5] . The influence is believed to be mediated any impact of low birth weight or the intrauterine environment on in vivo insulin secretion in man [7, 15, 18] .
Intrauterine malnutrition and foetal growth restriction is more likely to occur in twins compared to singletons because of their shared uterine environment [20] . Monozygotic (MZ) twins are often monochorionic and share the same placenta. Due to sharing of the same nutritive source and the development of vascular anastamoses, monochorionic twins could have a different and possibly more adverse intrauterine environment compared to dizygotic (DZ) and dichorionic MZ twins having separate placentas [21] . According to the foetal programming hypothesis MZ twins could therefore be more prone to develop various metabolic abnormalities.
We have recently shown increased glucose and insulin areas under the curves after oral glucose ingestion in elderly MZ twins compared with DZ twins supporting the hypothesis of an impact of zygosity status for the development of insulin resistance among twins [22] . These results, however, were based upon indirect estimates of insulin resistance (i.e. oral glucose tolerance test).
Age could be one of the most important factors precipitating the metabolic abnormalities characterising Type II diabetes [23, 24] , and the influence of the intrauterine environment for the development of insulin resistance and other metabolic abnormalities could vary with age potentially becoming more pronounced with increasing age as indicated in a few rodent studies [25, 26] .
In this study we investigated the impact of zygosity status and birth weight on in vivo insulin secretion and insulin-action based upon "gold standard" methods in a young twin and elder twin cohort. In particular, insulin secretion was expressed in relation to insulin action acknowledging the inverse hyperbolic relationship between insulin secretion and insulin action [27] thereby providing an accurate estimate of the pancreatic beta-cell function. Information about length of gestation, birth length and in particular birth weight was obtained from the original midwife records. Intratwin pair correlation analyses were carried out among MZ twin pairs to assess if a non-genetically determined low birth weight could be associated with defects in insulin secretion and/or insulin action.
Subjects and methods
Subjects. Subjects were identified through The Danish Twin Register [28, 29, 30] . A random extract of same sex monozygotic (MZ) and dizygotic (DZ) twin pairs born in Funen County from 1931 to 1940 (57-66 years) and 1966 to 1975 (22-31 years) with available original midwife records including birth weight and length were initially included. All potential subjects identified according to these inclusion criteria were contacted and interviewed in order to exclude subjects fulfilling the exclusion criteria. The exclusion criteria were as following: Either twin from the pair not willing to participate, information of pre-or post maturity (birth >or < than 3 weeks from expected time point), known diabetes, serious heart, liver or kidney disease, medication with influence on glucose or lipid metabolism including oral contraception which could not be withdrawn and pregnancy/lactation.
A total of 98 twin pairs (33 younger monozygotic; 22 younger dizygotic; 21 elder monozygotic; 22 elder dizygotic) were included in the clinical examination, including an oral glucose tolerance test (OGTT). Among the elder MZ twins 76.2% had normal glucose tolerance (NGT), 19.0% had impaired glucose tolerance (IGT) and 4.8% had previously unknown Type II diabetes. Among elder DZ twins 72.7% had NGT, 25.0% had IGT and 2.3% had previously unknown Type II diabetes. All younger DZ twins had NGT and among younger MZ twins 97.0% were glucose tolerant and 3.0% had IGT. There was no significant difference in glucose tolerance status between MZ and DZ twins within each age group. Zygosity was determined by serological testing, the most valid method with a success rate exceeding 99% [31] . The study was approved by the regional ethics committees and the study was conducted according to the principles of the Helsinki Declaration.
Clinical examination. Subjects underwent a 2-day clinical examination separated by 1 to 2 weeks. The twins in each pair were investigated simultaneously. The subjects were instructed to abstain from strenuous physical activity for 24 h and to fast for 10-12 h before both examination days.
Day 1 included a standard 75 g OGTT. Peripheral venous blood was taken before oral glucose ingestion and subsequently 30, 60 and 120 min later. Weight and height were measured with the subjects in lightweight clothes with shoes removed and the BMI (weight (kg)/height (m 2 )) was calculated. Waist circumference was measured using a soft tape on standing subjects midway between the lowest rib and the iliac crest. Hip circumference was measured over the widest part of the gluteal region, and the waist to hip ratio was calculated accordingly. Body composition, i.e. lean body mass and fat mass, was determined by DEXA scanning.
On day 2 subjects underwent a 2-h hyperinsulinaemic, euglycaemic clamp (40 mU·m -2 ·min -1 ) preceded by a 30 min intravenous glucose tolerance test (IVGTT). Polyethylene catheters were placed in the antecubital vein for infusion and in the contralateral dorsal hand or antecubital vein for blood sampling. This "sampling" hand was placed in a heated Plexiglas box to ensure arterialization of the venous blood sample. After a 2-h basal period an intravenous glucose bolus (0.3 g/kg body weight) was given over 1 min. Blood samples for glucose and insulin measurements were drawn at 0, 2, 4, 6, 8, 10, 15, 20 and 30 min. After the IVGTT a primed-continuous insulin infusion (40 mU·m -2 ·min -1 ) was initiated and continued for 2 h. A steady state was defined as the last 30 min of the 2 h clamp period. A variable infusion of glucose (180 g/l) maintained euglycaemia during insulin infusion. Plasma glucose concentration was monitored every 5 to 10 min during the basal and clamp periods using an automated glucose oxidation method (Glucose Analyser 2, Beckman Instruments, Fullerton, Calif., USA). Blood samples were drawn for measurements of glucose and insulin every 10 to 30 min during the basal and clamp steady state periods.
Analytical methods. Plasma glucose concentrations were analysed by the glucose dehydrogenase oxidation method. Plasma insulin concentrations were measured using a two-site, twostep, time resolved immunofluoremetric assay (DELFIA, Turku, Finland) as previously described [32] . Cross reactivities with proinsulin, C-peptide and Des-split [31, 32] product in the insulin assay were all less than 0.4%. Intraassay coefficients of variation in the physiological ranges were 3.6 to 4.3% for plasma insulin. Interassay coefficients of variation were 1.7 to 3.4% for plasma insulin. Intravenous glucose tolerance test. The total and incremental glucose and insulin areas under the curves (AUC) during IVGTT were calculated for the initial 10 min period (AUC 0-10 and incAUC 0-10 ). First phase insulin secretion was defined as incAUC 0-10 . Insulin response in relation to the glucose concentration (phi) was calculated as the AUC for insulin divided by the AUC for glucose during the initial 10 min of the IVGTT (AUC ins0-10 ×10 -9 /AUC glu0-10 ).
Hyperinsulinaemic and euglycaemic clamp. Insulin-stimulated glucose uptake, M, was defined as the glucose infusion rate during steady state. The M-values were expressed per kg lean body mass as determined by DEXA scan.
Disposition indices.
We calculated disposition indices (Di) in order to estimate the insulin secretion capacity in relation to insulin sensitivity acknowledging the inverse hyperbolic relationship between insulin secretion and insulin action (insulin secretion × insulin action). Di OGTT was calculated as (Ins inc0-30 ×M). Di IVGTT was calculated as (Phi IVGTT ×M).
Statistical methods. The variables were almost normally distributed and comparisons between MZ and DZ twins within each age group were therefore carried out using parametric analysis (Students t tests) for unpaired data. All tests were twotailed. Phenotypic correlations and intra-twin pair correlation analyses were done using Pearsons correlation. A p value of less than or equal to 0.05 was considered statistically significant. Data are shown as mean (SD).
Results
Clinical characteristics. The MZ twins were unintentionally slightly older compared with the DZ twins in the younger age group (Table 1) . Besides this, MZ and DZ twins were similar regarding current weight, height, BMI and WHR within each age group. Furthermore, no differences were found in birth weight, birth length or ponderal indices between MZ and DZ twins in either age group, Fig. 1A ). Table 2 ). Despite these differences, there was no difference in incremental insulin secretion between MZ and DZ twins in either age group. However, when expressing insulin secretion in relation to insulin sensitivity by means of Di, MZ twins showed lower insulin secretion compared to DZ among the elder twins (MZ: 0.52E-6 (0.38E-6); DZ: 0.71E-6 (0.57E-6), p=0.06), indicating that early insulin secretion is influenced by zygosity status. No such difference was detected among the younger twins.
Intravenous glucose tolerance test. No differences were seen in plasma glucose concentrations or AUC for glucose between MZ and DZ twins within each age group ( Fig. 2A and Table 3 ). Among younger twins, DZ twins had an insignificant but higher AUC 0 to 10 and first phase insulin secretion compared to MZ twins ( Fig. 2B and Table 3 ). Absolute insulin concentrations throughout the IVGTT, peak insulin concentration and first phase insulin secretion were similar among elderly MZ and DZ twins. In contrast to the findings during OGTT, we found similar early insulin response in relation to insulin resistance (Di) among MZ and DZ twins within both age groups. (Table 7) . 
Discussion
Our study shows that elderly MZ twins have metabolic abnormalities including insulin resistance and a disproportionately reduced insulin secretion in relation to insulin action compared with DZ twins. These findings are consistent with our previous findings providing mechanistic explanations for the increased plasma glucose and insulin profiles after oral glucose ingestion in MZ compared with DZ twins [22] . These differences between MZ and DZ twins were independent of the available parameters related to birth (i.e. birth weight, length and ponderal index) and adult anthropometry. The influence of zygosity status on insulin secretion and insulin-action showed a strong age -or time dependency as the metabolic defects associated with zygosity status first appeared with advanced age. In fact, in young age MZ twins showed a transient or initial favourable insulin action as compared to DZ twins. Whereas birth weight per se did not explain the impact of zygosity status on insulin secretion and action, we did in fact, using intra-pair correlation analyses in MZ twin pairs, find evidence of a non-genetically determined association between low birth weight and decreased insulin secretion as well as insulinaction in the elderly twins. Using this complementary approach to address the possible impact of the intrauterine environment in twins, we found some evidence of opposite relationships in young as compared with elderly twins. Thus, low birth weight was associated with a non-genetically determined disproportionately increased insulin secretion after both oral and intravenous glucose administration in young MZ twins, with a tendency towards an improved insulin action in young MZ twins. In contrast, low birth weight was associated with low insulin secretion as well as insulin action in the elderly MZ twins. Consequently, the two independent ways of analysing the present twin data both support the conclusion that ageing could play an important role in unmasking the influence of an adverse intrauterine environment on insulin resistance and low insulin secretion in twins. Studies on twin birth weights are rather inconsistent, however, chorionicity seems to be the most important predictor of birth weight and hence foetal environment [20, 33, 34] . Two-thirds of MZ twins are monochorionic and share the same placenta. Consequently, MZ twins are thought to experience a more adverse intrauterine environment compared to DZ twins particularly due to the placental circumstances characterising MZ pregnancies [21] . In our study, however, MZ and DZ twins had similar birth weights and lengths. This indicates that the influence of an adverse intrauterine environment on organ programming and adult glucose and insulin metabolism goes beyond the influence of birth weight per se, which in turn is consistent with the hypothesis that birth weight could only provide a crude estimate of the intrauterine environment. Among other factors, genetics seem to be an important determinant of birth weight [35] . The correlations between intrapair differences permit matching for common environmental effects (i.e. shared maternal/placental environment) and, in particular, among the MZ twins for the influence of genotype. The correlations in the MZ twins between intra-pair differences in birth parameters on one side, and insulin resistance or insulin secretion on the other side, is therefore primarily a result of the individual foeto-placental environment. It was only after we corrected for the impact of genetics on birth weight using intra-pair correlations in MZ twin pairs that we were able to detect any influence of birth weight per se on insulin secretion and insulin action especially in the elder twins. The lack of any consistent intra-pair correlations between birth weights and insulin secretion or insulin action in the DZ twins could also be explained by the impact of genetics on both birth weights on one side, and insulin secretion and insulin-action on the other side. However, the correlations between birth weights and insulin action as well as insulin secretion in the MZ twin pairs are unique in the sense that they show that non-genetic factors such as the intrauterine nutrition in addition to genetics could play a role for the development of insulin resistance and defective insulin secretion in elderly twins. In addition to similar birth anthropometry, we found similar adult anthropometry including current BMI, WHR and lean body mass between MZ and DZ twins in each age group. We were therefore able to control for several important factors with a documented influence on the metabolic variables, and in particular insulin action, measured in the study. Therefore, any differences shown in each age group could solely be explained by zygosity status per se.
While the lower insulin sensitivity among elder MZ twins compared to DZ twins is in accordance with what we expected from the thrifty phenotype hypothesis, and from our previous findings [22] , the greater insulin sensitivity among younger MZ compared to DZ twins was unexpected and could seem somewhat surprising. However, this finding is in accordance with findings in animal models showing transient improved glucose tolerance and insulin sensitivity among young (3 months) male offspring of protein-malnourished rats [25, 26] . These studies in rats together with our findings in humans indicate the important role of age in unmasking the impact of an adverse intrauterine environment for the development of insulin resistance. Interestingly, this documented age dependence of the impact of zygosity status on insulin action and glucose metabolism might explain why another study was unable to find any differences in glucose and insulin concentrations among MZ compared with DZ twins with a mean age of 44 years and a total age range of only 4 years [36] .
As opposed to our previous findings we were unable to find higher plasma glucose and insulin concentrations in the elderly MZ compared with DZ twins. An explanation for this could be the much smaller sample size in this study as compared to our previous study [22] , and the fact that only non-diabetic subjects were included. Including only healthy subjects resulted in a reduced variation in plasma glucose and insulin concentrations making the detection of small differences in the comparisons between MZ and DZ twins more difficult. Nevertheless, using the "gold standard" euglycaemic hyperinsulinaemic clamp technique we provided conclusive evidence for the presence of insulin resistance in elderly MZ compared with DZ twins as suggested from the much more indirect estimates of insulin action in the larger number of twins in our previous study [22] . Another study reported a higher second phase insulin secretion in MZ compared to DZ twins during an IVGTT in elderly MZ compared with DZ twins [37] supporting our finding of insulin resistance in elderly twins. In contrast, we found higher insulin AUC during the initial 30-min period of the OGTT in young DZ compared to young MZ twins. However, the incremental insulin secretion and disposition index were similar. We believe that this increased insulin response to oral glucose is a compensatory mechanism to the documented lower insulin action among younger DZ twins in order to maintain normoglycaemia. Accordingly, when evaluating insulin secretion it is important to take into account the inverse hyperbolic relation between insulin secretion and insulin action in vivo [27] . When expressing insulin secretion in relation to insulin sensitivity by means of disposition indices we found a reduced insulin secretion among elderly MZ compared to DZ twins after oral glucose administration, whereas we found similar insulin secretion in relation to insulin resistance in young MZ and DZ twins. Again, it is striking that low birth weight was associated with low insulin secretion in relation to insulin action (i.e. disposition indices) after both oral and intravenous glucose administration in the elderly MZ twin pairs, whereas the opposite was the case for the youngest MZ twin pairs (i.e. low birth weight was associated with increased insulin secretion in relation to insulin action). Therefore, the impact of age on insulin secretion disposition indices mimics the age dependency shown for the in vivo insulin action in the twins. Similarly, the insulin secretion results seem intrinsically consistent according to the age dependency regardless of whether the intrauterine component is estimated by the "zygosity criteria" or by birth weight intra-pair differences in the MZ twin pairs. It could be speculated that the biochemical mechanisms responsible for the age dependency of the early pre-programmed defects of both insulin secretion and insulin action might be similar.
The differences between MZ and DZ twins shown in this study challenges this major assumption of environmental (i.e. prenatal) similarity between MZ and DZ twins and, therefore, to some extent further questions the validity of the classic twin approach evaluating the relative importance of genes compared with environment on a given phenotype [22, 37] . However, this is of course only to the extent that the investigated phenotype has a prenatal etiological component. Accordingly, the results of this study are primarily of importance for twin studies of Type II diabetes, insulin resistance and associated diseases such as hypertension, obesity and dyslipoproteinaemia.
In conclusion, zygosity per se has a major impact on both in vivo insulin secretion and insulin action in twins. The impact seems to be age-dependent or timedependent with a higher insulin action in youngerand a lower insulin action in elderly MZ compared to DZ twins. The impact on insulin secretion was only apparent among elder twins with a lower insulin secretion in relation to insulin action in elder MZ compared to DZ twins. The impact of zygosity was not explained by differences in birth weights or other anthropometric measures usually associated with insulin action and insulin secretion. Nevertheless, in addition to the impact of zygosity status on glucose homeostasis, our study also showed non-genetic asso-ciations between low birth weight and defects of both insulin secretion as well as insulin action in elderly MZ twin pairs, and conversely between low birth weight and high insulin secretion in relation to insulin action in young MZ twins. Accordingly, the study provides additional support to the hypothesis of an intrauterine influence on the development of the pathophysiological mechanisms leading to Type II diabetes. Ageing could play an important role by in unmasking the influence of an adverse intrauterine environment on insulin resistance and low insulin secretion in twins.
